266 related articles for article (PubMed ID: 22082674)
1. Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart.
Liu W; Zi M; Naumann R; Ulm S; Jin J; Taglieri DM; Prehar S; Gui J; Tsui H; Xiao RP; Neyses L; Solaro RJ; Ke Y; Cartwright EJ; Lei M; Wang X
Circulation; 2011 Dec; 124(24):2702-15. PubMed ID: 22082674
[TBL] [Abstract][Full Text] [Related]
2. Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.
Egom EE; Mohamed TM; Mamas MA; Shi Y; Liu W; Chirico D; Stringer SE; Ke Y; Shaheen M; Wang T; Chacko S; Wang X; Solaro RJ; Fath-Ordoubadi F; Cartwright EJ; Lei M
Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1487-95. PubMed ID: 21705677
[TBL] [Abstract][Full Text] [Related]
3. Ventricular SK2 upregulation following angiotensin II challenge: Modulation by p21-activated kinase-1.
Yang B; Jiang Q; He S; Li T; Ou X; Chen T; Fan X; Jiang F; Zeng X; Huang CL; Lei M; Tan X
J Mol Cell Cardiol; 2022 Mar; 164():110-125. PubMed ID: 34774547
[TBL] [Abstract][Full Text] [Related]
4. A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin.
Liu W; Zi M; Tsui H; Chowdhury SK; Zeef L; Meng QJ; Travis M; Prehar S; Berry A; Hanley NA; Neyses L; Xiao RP; Oceandy D; Ke Y; Solaro RJ; Cartwright EJ; Lei M; Wang X
Circ Heart Fail; 2013 Jul; 6(4):833-44. PubMed ID: 23753531
[TBL] [Abstract][Full Text] [Related]
5. Smad3 Couples Pak1 With the Antihypertrophic Pathway Through the E3 Ubiquitin Ligase, Fbxo32.
Tsui H; Zi M; Wang S; Chowdhury SK; Prehar S; Liang Q; Cartwright EJ; Lei M; Liu W; Wang X
Hypertension; 2015 Dec; 66(6):1176-83. PubMed ID: 26483344
[TBL] [Abstract][Full Text] [Related]
6. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
7. FTY720 prevents ischemia/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1/Akt signaling.
Egom EE; Ke Y; Musa H; Mohamed TM; Wang T; Cartwright E; Solaro RJ; Lei M
J Mol Cell Cardiol; 2010 Feb; 48(2):406-14. PubMed ID: 19852968
[TBL] [Abstract][Full Text] [Related]
8. Pak1 is required to maintain ventricular Ca²⁺ homeostasis and electrophysiological stability through SERCA2a regulation in mice.
Wang Y; Tsui H; Ke Y; Shi Y; Li Y; Davies L; Cartwright EJ; Venetucci L; Zhang H; Terrar DA; Huang CL; Solaro RJ; Wang X; Lei M
Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):938-48. PubMed ID: 25217043
[TBL] [Abstract][Full Text] [Related]
9. Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy.
Jiang DS; Liu Y; Zhou H; Zhang Y; Zhang XD; Zhang XF; Chen K; Gao L; Peng J; Gong H; Chen Y; Yang Q; Liu PP; Fan GC; Zou Y; Li H
Hypertension; 2014 Apr; 63(4):713-22. PubMed ID: 24396025
[TBL] [Abstract][Full Text] [Related]
10. Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart.
Kimura TE; Jin J; Zi M; Prehar S; Liu W; Oceandy D; Abe J; Neyses L; Weston AH; Cartwright EJ; Wang X
Circ Res; 2010 Mar; 106(5):961-70. PubMed ID: 20075332
[TBL] [Abstract][Full Text] [Related]
11. Cdc42 is an antihypertrophic molecular switch in the mouse heart.
Maillet M; Lynch JM; Sanna B; York AJ; Zheng Y; Molkentin JD
J Clin Invest; 2009 Oct; 119(10):3079-88. PubMed ID: 19741299
[TBL] [Abstract][Full Text] [Related]
12. Cardiac-specific deletion of mkk4 reveals its role in pathological hypertrophic remodeling but not in physiological cardiac growth.
Liu W; Zi M; Jin J; Prehar S; Oceandy D; Kimura TE; Lei M; Neyses L; Weston AH; Cartwright EJ; Wang X
Circ Res; 2009 Apr; 104(7):905-14. PubMed ID: 19265040
[TBL] [Abstract][Full Text] [Related]
13. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
[TBL] [Abstract][Full Text] [Related]
14. C1QTNF1 attenuates angiotensin II-induced cardiac hypertrophy via activation of the AMPKa pathway.
Wu L; Gao L; Zhang D; Yao R; Huang Z; Du B; Wang Z; Xiao L; Li P; Li Y; Liang C; Zhang Y
Free Radic Biol Med; 2018 Jun; 121():215-230. PubMed ID: 29733904
[TBL] [Abstract][Full Text] [Related]
15. FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K.
Weeks KL; Tham YK; Yildiz SG; Alexander Y; Donner DG; Kiriazis H; Harmawan CA; Hsu A; Bernardo BC; Matsumoto A; DePinho RA; Abel ED; Woodcock EA; McMullen JR
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1470-H1485. PubMed ID: 33577435
[TBL] [Abstract][Full Text] [Related]
16. Novel Protective Role for Ubiquitin-Specific Protease 18 in Pathological Cardiac Remodeling.
Ying X; Zhao Y; Yao T; Yuan A; Xu L; Gao L; Ding S; Ding H; Pu J; He B
Hypertension; 2016 Nov; 68(5):1160-1170. PubMed ID: 27572150
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-Converting Enzyme 3 (ACE3) Protects Against Pressure Overload-Induced Cardiac Hypertrophy.
Yu CJ; Tang LL; Liang C; Chen X; Song SY; Ding XQ; Zhang KY; Song BL; Zhao D; Zhu XY; Li HL; Zhang ZR
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26892527
[TBL] [Abstract][Full Text] [Related]
18. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
19. ANGPTL8 is a negative regulator in pathological cardiac hypertrophy.
Hu L; Wei J; Zhang Y; Wang Z; Tang J; Tang J; Gao Y; Zhang X; Li Y; Liu Y; Ma S; Guo X; Zhang Q
Cell Death Dis; 2022 Jul; 13(7):621. PubMed ID: 35851270
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor receptor-associated factor 3 is a positive regulator of pathological cardiac hypertrophy.
Jiang X; Deng KQ; Luo Y; Jiang DS; Gao L; Zhang XF; Zhang P; Zhao GN; Zhu X; Li H
Hypertension; 2015 Aug; 66(2):356-67. PubMed ID: 26034202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
